Wellington Management Discloses Significant Stake in Rocket Pharma

TL;DR

**Wellington Management Group just revealed a big stake in Rocket Pharma, signaling institutional confidence.**

AI Summary

Wellington Management Group LLP, a major investment firm, reported on February 8, 2024, that it holds a significant stake in Rocket Pharmaceuticals, Inc. as of December 29, 2023. This filing indicates that Wellington Management Group LLP is a substantial institutional investor in Rocket Pharmaceuticals, a company focused on pharmaceutical preparations. This matters to investors because large institutional holdings can signal confidence in the company's future prospects and stability, potentially influencing stock price and liquidity.

Why It Matters

This filing reveals a major institutional investor's confidence in Rocket Pharmaceuticals, which can positively influence market perception and potentially attract other investors.

Risk Assessment

Risk Level: low — This filing indicates a large institutional investment, generally seen as a positive signal, thus presenting low risk.

Analyst Insight

Smart investors should view this as a positive signal, indicating institutional confidence in Rocket Pharmaceuticals, and consider further research into the company's fundamentals and future prospects.

Key Players & Entities

• Wellington Management Group LLP (company) — the reporting person and institutional investor
• Rocket Pharmaceuticals, Inc. (company) — the subject company whose stock is being reported
• December 29, 2023 (date) — the date of the event requiring the filing
• February 8, 2024 (date) — the filing date of the SC 13G

Forward-Looking Statements

• Rocket Pharmaceuticals' stock may experience increased stability due to Wellington Management Group LLP's significant institutional holding. (Rocket Pharmaceuticals, Inc.) — medium confidence, target: Q2 2024

FAQ

Filing Documents

• SEC13G_Filing.htm (SC 13G) — 35KB
• 0000902219-24-000121.txt ( ) — 37KB

From the Filing

SC 13G 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ ) * Rocket Pharmaceuticals, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 77313F106 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 77313F106 1. NAMES OF REPORTING PERSONS Wellington Management Group LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 7,363,699 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,197,546 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,197,546 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.09% 12. TYPE OF REPORTING PERSON HC CUSIP No. 77313F106 1. NAMES OF REPORTING PERSONS Wellington Group Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 7,363,699 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,197,546 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,197,546 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.09% 12. TYPE OF REPORTING PERSON HC CUSIP No. 77313F106 1. NAMES OF REPORTING PERSONS Wellington Investment Advisors Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 7,363,699 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,197,546 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,197,546 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.09% 12. TYPE OF REPORTING PERSON HC CUSIP No. 77313F106 1. NAMES OF REPORTING PERSONS Wellington Management Company LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 7,331,142 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 7,876,583 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,876,583 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.74% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Rocket Pharmaceuticals, Inc. (b) Address of Issuer's Principal Executive Offices 9 Cedarbrook Drive Cranbury, NJ 08512 Item 2. (a) Name of Person Filing Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP Wellington Management Company LLP (b) Address of Principal Business Office or, if None, Residence c/o Wellington Management Company LLP 280 Congress Street Boston, MA 02210 (c) Citizenship Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware Wellington Management Company LLP - Delaware (d) Title of Class of Securities Common Stock (e) CUSIP Number 77313F106 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined i

View Full Filing

View this SC 13G filing on SEC EDGAR